Literature DB >> 24330081

Enhanced nicotinic receptor mediated relaxations in gastroesophageal muscle fibers from Barrett's esophagus patients.

L S Miller1, A K Vegesna, A S Braverman, M F Barbe, M R Ruggieri.   

Abstract

BACKGROUND: Increased nicotinic receptor mediated relaxation in the gastroesophageal antireflux barrier may be involved in the pathophysiology of reflux. This study is designed to determine whether the defects we previously identified in gastroesophageal reflux disease patients in- vivo are due to abnormalities of the gastric sling, gastric clasp, or lower esophageal circular (LEC) muscle fibers.
METHODS: Muscle strips from whole stomachs and esophagi were obtained from 16 normal donors and 15 donors with histologically proven Barrett's esophagus. Contractile and relaxant responses of gastric sling, gastric clasp, or LEC fibers were determined to increasing concentrations of carbachol and to nicotine after inducing maximal contraction to bethanechol. Muscarinic receptor density was measured using subtype selective immunoprecipitation. KEY
RESULTS: Barrett's esophagus gastric sling and LEC fibers have decreased carbachol-induced contractions. Barrett's esophagus sling fibers have decreased M2 -muscarinic receptors and LEC fibers have decreased M3 receptors. Relaxations of all three fiber types are greater in Barrett's esophagus specimens to both high carbachol concentrations and to nicotine following bethanechol precontraction. The maximal response to bethanechol is greater in Barrett esophagus sling and LEC fibers. CONCLUSIONS & INFERENCES: The increased contractile response to bethanechol in Barrett's specimens indicates that the defect is likely not due to the smooth muscle itself. The enhanced nicotinic receptor mediated response may be involved in greater relaxation of the muscles within the high-pressure zone of the gastroesophageal junction during transient lower esophageal sphincter relaxations and during deglutitive inhibition and may be involved in the pathophysiology of gastroesophageal reflux disease.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  Barrett's esophagus; gastroesophageal reflux disease; nicotinic receptors; smooth muscle relaxation

Mesh:

Substances:

Year:  2013        PMID: 24330081      PMCID: PMC4019224          DOI: 10.1111/nmo.12294

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  16 in total

1.  Neuromuscular function of the human lower oesophageal sphincter in reflux disease and Barrett's oesophagus.

Authors:  S D Smid; L A Blackshaw
Journal:  Gut       Date:  2000-06       Impact factor: 23.059

2.  Factors that influence induction of gastroesophageal reflux in normal human subjects.

Authors:  J Dent; W J Dodds; W J Hogan; J Toouli
Journal:  Dig Dis Sci       Date:  1988-03       Impact factor: 3.199

3.  Muscarinic acetylcholine receptor subtypes mediating urinary bladder contractility and coupling to GTP binding proteins.

Authors:  P Wang; G R Luthin; M R Ruggieri
Journal:  J Pharmacol Exp Ther       Date:  1995-05       Impact factor: 4.030

Review 4.  Use of endoluminal ultrasound to evaluate gastrointestinal motility.

Authors:  Larry Miller; Qing Dai; Annapurna Korimilli; Barry Levitt; Zeeshan Ramzan; James Brasseur
Journal:  Dig Dis       Date:  2006       Impact factor: 2.404

5.  Induced opening of the gastroesophageal junction occurs at a lower gastric pressure in gerd patients and in hiatal hernia subjects than in normal control subjects.

Authors:  Anil Vegesna; Ramashesai Besetty; Amit Kalra; Umar Farooq; Annapurna Korimilli; Keng Yu Chuang; Robert Fisher; Henry Parkman; Larry Miller
Journal:  Gastroenterol Res Pract       Date:  2010-03-18       Impact factor: 2.260

6.  Pharmacological dissection of the human gastro-oesophageal segment into three sphincteric components.

Authors:  James G Brasseur; Rhys Ulerich; Qing Dai; Dalipkumar K Patel; Ahmed M S Soliman; Larry S Miller
Journal:  J Physiol       Date:  2007-02-08       Impact factor: 5.182

7.  Antibodies to a synthetic peptide can be used to distinguish between muscarinic acetylcholine receptor binding sites in brain and heart.

Authors:  G R Luthin; J Harkness; R P Artymyshyn; B B Wolfe
Journal:  Mol Pharmacol       Date:  1988-09       Impact factor: 4.436

8.  Muscular equivalent of the lower esophageal sphincter.

Authors:  D Liebermann-Meffert; M Allgöwer; P Schmid; A L Blum
Journal:  Gastroenterology       Date:  1979-01       Impact factor: 22.682

9.  A missing sphincteric component of the gastro-oesophageal junction in patients with GORD.

Authors:  L Miller; Q Dai; A Vegesna; A Korimilli; R Ulerich; B Schiffner; J Brassuer
Journal:  Neurogastroenterol Motil       Date:  2009-03-13       Impact factor: 3.598

10.  Characteristics and frequency of transient relaxations of the lower esophageal sphincter in patients with reflux esophagitis.

Authors:  R K Mittal; R W McCallum
Journal:  Gastroenterology       Date:  1988-09       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.